Virta Health Stock

virtahealth.comHealthcare / Healthcare providers & servicesFounded: 2014Funding to Date: $365.01MM

Virta Health, founded in 2014, is a healthcare company that specializes in the development of a clinically-proven treatment for type 2 diabetes and other chronic metabolic diseases. The treatment is designed to reverse these conditions safely and sustainably without the need for medications or surgery. Virta Health's solution is based on a combination of technology, medical expertise, and personalized coaching. The company's mission is to help patients achieve optimal health outcomes and improve their quality of life. Virta Health is based in San Francisco, California.

Register To Buy and Sell Shares

For more details on financing and valuation for Virta Health, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Virta Health’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Virta Health.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Manu Diwakar
Chief Financial Officer
Amit Shah
Chief Operating Officer
Shane Henderson
Chief Technology Officer
Jeff Volek Ph.D
Co-Founder & Chief Science Officer
Sami Inkinen
Co-Founder, Chief Executive Officer & Board Member

Board Members

Bob Kocher MD
Venrock

Frequently Asked Questions About Virta Health’s Stock

plusminus
Can you buy Virta Health’s stock?
Virta Health is not publicly traded on NYSE or NASDAQ in the U.S. To buy Virta Health’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Virta Health’s stock?
Yes, you can sell stock of a private company like Virta Health. Forge can help you sell your Virta Health stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Virta Health’s stock price?
Virta Health is a privately held company and therefore does not have a public stock price. However, you may access Virta Health’s private market stock price with Forge Data.
plusminus
What is Virta Health’s stock ticker symbol?
Virta Health does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Virta Health: $93 Million Raised To Take On Type 2 Diabetes Epidemic And Expand Diabetes Reversal
Virta Health – the first company with a treatment to sustainably reverse type 2 diabetes (T2D) without medications or surgery – announced that it has raised $93 million in Series C funding to combat the growing prevalence of Type 2 Diabetes (T2D), bringing the total equity funding to $166 million.
Blue Shield of California Adds Virta Health to Its Provider Network to Help Reverse the State's Growing Type 2 Diabetes Epidemic
Blue Shield of California today announced an expanded partnership with Virta Health, the leader in type 2 diabetes reversal, as Virta joins the nonprofit health plan's statewide provider network for 2023. Virta is the first digital diabetes solution to be fully covered for eligible members under Blue Shield's benefits program.
Diabetes Reversal Leader Virta Health Deepens Executive Bench Amid Triple-Digit Year-Over-Year Growth
Virta Health, the leader in type 2 diabetes reversal, is expanding its C-suite as the company scales to meet heightened demand for its chronic disease reversal solutions.
Updated on: Apr 14, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.